Asia-Pacific biologics market is estimated to grow at a CAGR of 9.2% during the forecast period. Some pivotal factors accelerating market growth include the rising prevalence of cancer and increasing launches of biologics therapy. As per the World Health Organization (WHO), in Asia, the number of new cancer incidences expected to be reported in 2020 will be nearly 9.5 million. This, in turn, is leading to an increasing demand for biologics drugs which acts as an immune system substance that supports to augment the body’s ability to fight against cancer. Biologics comprises a comprehensive range of drugs that particularly target cancer cells, encourage the immune response, and support the recovery from cancer treatment. These drugs are normally utilized in combination with other therapies, including chemotherapy.

Free Sample Copy @ https://www.omrglobal.com/request-sample/asia-pacific-biologics-market

Asia-Pacific biologics market is segmented based on product and application. Based on the product, the market is segmented into antibody therapeutics, vaccines, cell therapy, gene therapy, and others. A large number of biologics available in the market are monoclonal antibodies and several products are in the pipeline. Over the decades, advances in the improvement of the humanization of monoclonal antibodies have been witnessed, which, in turn, improves efficacy and decreasing immunogenicity. Monoclonal antibodies are regarded as highly targeted drugs, binds to the cancerous cells, and poison the tumor to destroy it. One instance of a biological drug includes Trastuzumab, which is utilized in particular for metastatic breast cancer in women. Another instance is Rituxan, which is utilized to support the treatment of non-Hodgkin’s lymphoma. Based on application, the market is segmented into cancer, autoimmune diseases, infectious diseases, and others.

A Full Report of Asia-Pacific Biologics Market is Available at:
https://www.omrglobal.com/industry-reports/asia-pacific-biologics-market

The market study of the Asia-Pacific biologics market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity in our reports.

Asia-Pacific Biologics Market – Segmentation
by Product
Antibody Therapeutics
Vaccines
Cell Therapy
Gene Therapy
Others
by Application
Cancer
Autoimmune Diseases
Infectious Diseases
Others

Asia-Pacific Biologics Market – Segmentation by Region 
China
Japan
India
Rest of Asia-Pacific

Company Profiles
AbbVie, Inc.
Amgen, Inc.
Aurobindo Pharma, Ltd.
Biocon, Ltd.
Biological E. Ltd.
Boehringer Ingelheim GmbH
Cipla, Ltd.
Daiichi Sankyo Company, Ltd.
Eli Lilly and Co.
F. Hoffman-La Roche AG
Innovent Biologics, Inc.
Intas Pharmaceuticals, Ltd.
Shanghai Henlius Biotech Inc. (Shanghai Fosun Pharmaceutical Co., Ltd.)


For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-biologics-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected] 
Contact no: +91 780-304-0404